ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Latest Insider Confidence Score

2026Q1

57.9
Bullish

Company insider confidence (by quarter)

2013Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Alnylam Pharmaceuticals, Inc. 10% Owner 4,896,716 Feb 24, 2016
Schimmel Paul Director 306,996 Dec 22, 2015
Sharp Phillip A Director 266,899 Dec 22, 2020
Maraganore John CEO 49,457 May 17, 2019
Pyott David E I Director 27,900 Oct 14, 2016

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 6, 2026 Garg Pushkal EVP Chief R&D Sell 18.8 -4,713 -19.57% ✓ $1.5M
Mar 4, 2026 Mar 6, 2026 Greenstreet Yvonne CEO Sell 40.0 -2,933 -2.96% ✗ $947.6K
Mar 4, 2026 Mar 6, 2026 Poulton Jeffrey V. CFO Sell 40.0 -2,468 -3.84% ✗ $797.4K
Mar 4, 2026 Mar 6, 2026 Tanguler Tolga EVP, Chief Commercial Officer Sell 40.0 -2,309 -6.31% ✗ $746K
Mar 4, 2026 Mar 6, 2026 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 32.5 -1,291 -5.76% ✓ $417.7K
Mar 2, 2026 Mar 4, 2026 Poulton Jeffrey V. CFO Sell 90.0 +2,563 4.15% ✗ $722.8K
Mar 2, 2026 Mar 4, 2026 Garg Pushkal EVP Chief R&D Sell 95.0 +1,277 5.60% ✓ $1.1M
Mar 2, 2026 Mar 4, 2026 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 87.5 +438 1.99% ✓ $1.1M
Mar 2, 2026 Mar 4, 2026 Tanguler Tolga EVP, Chief Commercial Officer Sell 92.5 +3,171 9.48% ✗ $523.6K
Mar 2, 2026 Mar 4, 2026 SUPRAN BRYAN EVP, CLO and Secretary Neutral 90.0 +1,539 11.81% ✗ -
Mar 2, 2026 Mar 4, 2026 Greenstreet Yvonne CEO Sell 95.0 +7,045 7.66% ✗ $2.2M
Feb 27, 2026 Mar 2, 2026 Greenstreet Yvonne CEO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 2, 2026 Poulton Jeffrey V. CFO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 2, 2026 Tanguler Tolga EVP, Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 2, 2026 Garg Pushkal EVP Chief R&D Sell 18.8 -4,627 -16.86% ✓ $1.5M
Feb 23, 2026 Feb 25, 2026 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Neutral 67.5 +158 0.72% ✗ -
Feb 12, 2026 Feb 17, 2026 Garg Pushkal EVP Chief R&D Sell 97.5 +2,337 10.08% ✗ $695.2K
Feb 12, 2026 Feb 17, 2026 Greenstreet Yvonne CEO Sell 95.0 +7,251 9.20% ✗ $2.2M
Feb 12, 2026 Feb 17, 2026 Tanguler Tolga EVP, Chief Commercial Officer Sell 92.5 +2,041 6.87% ✗ $607.4K
Feb 12, 2026 Feb 17, 2026 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 52.5 - 0.00% ✓ $1.3M
Feb 12, 2026 Feb 17, 2026 Poulton Jeffrey V. CFO Sell 90.0 +2,337 4.06% ✗ $695.2K
Jan 11, 2026 Jan 14, 2026 Garg Pushkal EVP Chief R&D Sell 97.5 +2,290 10.96% ✗ $547.9K
Jan 11, 2026 Jan 14, 2026 Greenstreet Yvonne CEO Sell 100.0 +9,426 13.58% ✗ $3.5M
Jan 11, 2026 Jan 14, 2026 Poulton Jeffrey V. CFO Sell 95.0 +3,413 6.31% ✗ $1M
Jan 11, 2026 Jan 14, 2026 Tanguler Tolga EVP, Chief Commercial Officer Sell 92.5 +2,290 8.35% ✗ $547.9K
Jan 11, 2026 Jan 14, 2026 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 52.5 - 0.00% ✓ $1.4M
Jan 5, 2026 Jan 7, 2026 Arbuckle Stuart A Director Neutral 52.5 - 0.00% ✗ -
Jan 7, 2026 Arbuckle Stuart A Director Neutral 52.5 - 0.00% ✗ -
Nov 26, 2025 Dec 1, 2025 Greenstreet Yvonne CEO Sell 20.0 -1,121 -1.59% ✗ $499K
Nov 17, 2025 Nov 19, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 3.8 -12,128 -35.75% ✓ $5.5M
Nov 12, 2025 Nov 14, 2025 Greenstreet Yvonne CEO Sell 37.5 -25,650 -1.77% ✓ $11.6M
Oct 1, 2025 Oct 3, 2025 SUPRAN BRYAN EVP, CLO and Secretary Neutral 90.0 +13,026 100.00% ✗ -
Oct 1, 2025 Oct 3, 2025 Poulton Jeffrey V. CFO Sell 95.0 +3,931 7.83% ✗ $1.7M
Oct 1, 2025 Oct 3, 2025 Greenstreet Yvonne CEO Sell 100.0 +9,188 16.23% ✗ $4M
Oct 1, 2025 Oct 3, 2025 Tanguler Tolga EVP, Chief Commercial Officer Sell 92.5 +1,446 5.56% ✗ $635.1K
Oct 1, 2025 Oct 3, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 100.0 +2,512 10.80% ✗ $1.1M
Oct 1, 2025 Oct 3, 2025 Garg Pushkal EVP Chief R&D Sell 48.8 - 0.00% ✓ $2.7M
Sep 22, 2025 SUPRAN BRYAN EVP, CLO and Secretary Neutral 52.5 - 0.00% ✗ -
Sep 9, 2025 Sep 11, 2025 Reitan Colleen F Director Sell 3.8 -18,000 -95.87% ✓ $8.4M
Aug 29, 2025 Sep 2, 2025 Tanguler Tolga EVP, Chief Commercial Officer Sell 20.0 -3,474 -11.79% ✓ $1.6M
Aug 15, 2025 Aug 19, 2025 Garg Pushkal EVP Chief R&D Sell 48.8 - 0.00% ✓ $1.3M
Aug 15, 2025 Aug 19, 2025 Tanguler Tolga EVP, Chief Commercial Officer Sell 92.5 +1,455 5.19% ✗ $632.8K
Aug 15, 2025 Aug 19, 2025 Poulton Jeffrey V. CFO Sell 92.5 +2,370 4.96% ✗ $1M
Aug 15, 2025 Aug 19, 2025 Greenstreet Yvonne CEO Sell 100.0 +7,273 14.74% ✗ $3.2M
Aug 15, 2025 Aug 19, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 92.5 +1,455 6.67% ✗ $632.8K
Aug 18, 2025 Aug 19, 2025 BONNEY MICHAEL W Director Sell 3.8 -11,250 -35.10% ✓ $5.1M
Aug 14, 2025 Aug 15, 2025 Ausiello Dennis A Director Sell 2.5 -31,448 -87.70% ✓ $13.7M
Jul 1, 2025 Jul 2, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Neutral 90.0 +7,763 55.30% ✗ -
May 30, 2025 Jun 3, 2025 Greenstreet Yvonne CEO Sell 7.5 -50,937 -24.93% ✓ $15.5M
May 15, 2025 May 19, 2025 BONNEY MICHAEL W Director Sell 5.0 -11,250 -35.10% ✓ $3.1M
May 16, 2025 May 19, 2025 Greenstreet Yvonne CEO Neutral 27.5 -8,376 -14.51% ✗ -
May 8, 2025 May 12, 2025 Ausiello Dennis A Director Neutral 90.0 +775 21.31% ✗ -
May 8, 2025 May 12, 2025 BONNEY MICHAEL W Director Neutral 82.5 +775 3.87% ✗ -
May 8, 2025 May 12, 2025 BRANDICOURT OLIVIER Director Neutral 90.0 +775 100.00% ✗ -
May 8, 2025 May 12, 2025 HAMBURG MARGARET A Director Neutral 90.0 +775 569.85% ✗ -
May 8, 2025 May 12, 2025 KELLOGG PETER N Director Neutral 90.0 +775 100.00% ✗ -
May 8, 2025 May 12, 2025 PYOTT DAVID E I Director Neutral 82.5 +775 2.76% ✗ -
Aug 29, 2024 May 12, 2025 Reitan Colleen F Director Buy 90.0 +775 100.00% ✗ $2K
May 8, 2025 May 12, 2025 SCHULMAN AMY W Director Neutral 85.0 +775 6.93% ✗ -
May 8, 2025 May 12, 2025 Sigal Charles Elliott Director Neutral 90.0 +775 38.75% ✗ -
May 8, 2025 May 12, 2025 Bertozzi Carolyn R Director Neutral 90.0 +775 100.00% ✗ -
May 2, 2025 May 6, 2025 Greenstreet Yvonne CEO Neutral 27.5 -41,311 -41.71% ✗ -
Mar 21, 2025 Mar 25, 2025 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 15.0 -9,766 -19.19% ✓ $2.9M
Mar 24, 2025 Mar 25, 2025 PYOTT DAVID E I Director Sell 10.0 -7,440 -20.97% ✓ $2.2M
Mar 13, 2025 Mar 14, 2025 SCHULMAN AMY W Director Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 5, 2025 Hesslein Robert W. EVP, CLO and Secretary Neutral 90.0 +757 10.45% ✗ -
Mar 3, 2025 Mar 5, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 92.5 +1,116 8.64% ✓ $669.3K
Mar 3, 2025 Mar 5, 2025 Tanguler Tolga EVP, Chief Commercial Officer Sell 95.0 +13,666 95.27% ✗ $114.8K
Mar 3, 2025 Mar 5, 2025 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 97.5 +11,580 84.88% ✓ $621.2K
Mar 3, 2025 Mar 5, 2025 Poulton Jeffrey V. CFO Sell 97.5 +13,853 40.80% ✗ $308.1K
Mar 3, 2025 Mar 5, 2025 Greenstreet Yvonne CEO Sell 97.5 +14,088 16.58% ✗ $945.2K
Feb 27, 2025 Mar 3, 2025 Greenstreet Yvonne CEO Sell 40.0 -2,900 -3.30% ✗ $700.9K
Feb 27, 2025 Mar 3, 2025 Poulton Jeffrey V. CFO Sell 42.5 -796 -2.29% ✗ $192.4K
Feb 27, 2025 Mar 3, 2025 Tanguler Tolga EVP, Chief Commercial Officer Sell 42.5 -513 -3.45% ✗ $124K
Feb 27, 2025 Mar 3, 2025 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 42.5 -935 -6.41% ✗ $226K
Feb 28, 2025 Mar 3, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 42.5 -496 -3.70% ✗ $119.9K
Feb 13, 2025 Feb 18, 2025 Greenstreet Yvonne CEO Sell 90.0 +2,646 3.34% ✗ $309.5K
Feb 13, 2025 Feb 18, 2025 Poulton Jeffrey V. CFO Sell 90.0 +2,142 6.98% ✗ $246.7K
Feb 13, 2025 Feb 18, 2025 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 51.3 - 0.00% ✓ $531.4K
Feb 13, 2025 Feb 18, 2025 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 51.3 - 0.00% ✓ $787.9K
Jan 27, 2025 Jan 29, 2025 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 2.5 -52,592 -80.59% ✓ $15M
Jan 23, 2025 Jan 24, 2025 SHARP PHILLIP A Director Sell 32.5 -11,250 -4.04% ✓ $3.1M
Dec 12, 2024 Dec 13, 2024 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 26.3 -1,752 -9.66% ✓ $439.8K
Nov 25, 2024 Nov 27, 2024 Greenstreet Yvonne CEO Sell 95.0 +5,439 7.37% ✗ $1.3M
Nov 25, 2024 Nov 27, 2024 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 97.5 +1,752 10.69% ✗ $422.1K
Nov 25, 2024 Nov 27, 2024 Poulton Jeffrey V. CFO Sell 92.5 +1,752 6.05% ✗ $422.1K
Nov 25, 2024 Nov 27, 2024 Tanguler Tolga EVP, Chief Commercial Officer Sell 97.5 +1,531 13.13% ✗ $368.7K
Nov 25, 2024 Nov 27, 2024 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 51.3 - 0.00% ✓ $754.9K
Oct 8, 2024 Oct 10, 2024 Garg Pushkal CMO & EVP Dev & Med Affairs Neutral 67.5 +96 0.59% ✗ -
Oct 1, 2024 Oct 3, 2024 Hesslein Robert W. EVP, CLO and Secretary Neutral 90.0 +7,245 100.00% ✗ -
Oct 3, 2024 Hesslein Robert W. EVP, CLO and Secretary Neutral 52.5 - 0.00% ✗ -
Aug 20, 2024 Aug 22, 2024 Greenstreet Yvonne CEO Sell 15.0 -15,000 -16.88% ✓ $4.2M
Aug 12, 2024 Aug 14, 2024 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sell 3.8 -22,025 -62.14% ✓ $6M
Aug 6, 2024 Aug 8, 2024 Ausiello Dennis A Director Sell 3.8 -20,250 -84.78% ✓ $5.3M
Aug 1, 2024 Aug 2, 2024 Greenstreet Yvonne CEO Sell 15.0 -15,148 -17.02% ✓ $4.1M
Jul 11, 2024 Jul 12, 2024 Greenstreet Yvonne CEO Sell 23.8 -7,093 -8.76% ✓ $1.9M
Jun 25, 2024 Jun 27, 2024 SCHULMAN AMY W Director Sell 5.0 -8,500 -50.19% ✓ $2M
Jun 24, 2024 Jun 26, 2024 PYOTT DAVID E I Director Sell 3.8 -32,450 -53.65% ✓ $7.2M
Jun 24, 2024 Jun 26, 2024 Garg Pushkal CMO & EVP Dev & Med Affairs Sell 97.5 +2,192 15.55% ✗ $485.8K
Jun 24, 2024 Jun 26, 2024 Greenstreet Yvonne CEO Sell 100.0 +8,652 11.97% ✗ $1.9M